alodokter

Alodokter previously secured a US$5.2 million funding round in early 2024 and has over 20 million monthly active users.

Some laid-off employees and 30 worker solidarity members held a rally outside the firm’s Jakarta office last week.

This week’s On the Rise delves into the employee protests at Aldokter and the latest escalation in the US-China chip war.

The SoftBank-backed healthtech firm insists it followed regulations, but affected workers strongly disagree.

We look at the Indonesian healthtech firm’s results for the 2022 financial year and fintech company Julo hitting breakeven.

The Indonesian healthtech platform reduced its expenses significantly across categories like employee compensation and advertising.

The company declined to disclose its valuation, though Alternatives.pe pegs it at US$136.1 million.

The country’s new omnibus healthcare law finally gives healthtech players a framework after years of no guidance.

This week’s On the Rise looks at investors caught in the US-China trade war, the impact of purpose-bound money, and an autonomous AI system.

Alodokter has also raised US$6 million from Optima Health, according to VentureCap Insights data.